Dividends
Aspen Pharmacare pays an annual dividend of $0.12 per share and has a dividend yield of 1.3%. Marui Group pays an annual dividend of $0.97 per share and has a dividend yield of 2.4%. Marui Group pays out 53.0% of its earnings in the form of a dividend.
Profitability
This table compares Aspen Pharmacare and Marui Group’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Aspen Pharmacare | N/A | N/A | N/A |
Marui Group | 10.31% | 11.24% | 2.68% |
Earnings & Valuation
This table compares Aspen Pharmacare and Marui Group”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Aspen Pharmacare | $2.39 billion | 1.71 | $235.61 million | N/A | N/A |
Marui Group | $1.63 billion | 2.29 | $170.20 million | $1.83 | 21.78 |
Volatility & Risk
Aspen Pharmacare has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500. Comparatively, Marui Group has a beta of 0.26, meaning that its share price is 74% less volatile than the S&P 500.
Summary
Marui Group beats Aspen Pharmacare on 5 of the 9 factors compared between the two stocks.
About Aspen Pharmacare
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
About Marui Group
Marui Group Co., Ltd., an investment holding company, engages in the retailing and FinTech businesses in Japan. The company engages in the design and construction of commercial facilities; advertising planning and production; property management; rental of real estate properties; small-amount short-term insurance policy business; and sale of investment trusts. It is also involved in the operation of websites; contract store opening and operation services; provision of credit card services; operation of Marui/Modi stores; investing and financing direct-to-consumer businesses; internet sales; specialty store; credit loan; collection and management of receivables; credit check; trucking and forwarding; software development; and operation of IT systems, and building management businesses. The company was founded in 1931 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.